Cancer clinical trial aims to activate immune system
A new Sanford Health clinical trial will explore a drug’s ability to activate the body’s immune system to fight head and neck cancer. Oncologist and cancer researcher Steven Powell, M.D., developed and will lead the Merck Investigator Studies Program (MISP) trial using the investigational drug pembrolizumab in combination with chemotherapy and radiation therapy for participants […]
⋅ 4 min read
Clinical trials: ‘Increased treatment options’
David Pearce, president of Sanford Research, recently talked to MED Magazine about clinical trials.
⋅ 2 min read
Breast cancer journeys different for every woman
Sanford Bemidji's entire oncology team works together to develop treatment plans to fit each patient's specific needs both medically and emotionally.
⋅ 5 min read
Sanford to help improve access to health care across Africa
Two leaders in bringing health equity to global locations are collaborating to improve care in Africa. Sanford International Clinics and Global Health Corps have partnered to enhance the level of care in developing parts of the continent. The two organizations, which both have an existing presence in Africa, will work to develop health care professionals […]
⋅ 5 min read
Kidney transplant, dialysis save life of Minnesota man
Jeff Prins is grateful for the person who chose to be an organ donor and the care of Sanford Health.
⋅ 5 min read
